Ramires, F. J.A. et al. (2018) Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al. ESC Heart Failure, 5(6), pp. 1069-1071. (doi: 10.1002/ehf2.12355) (PMID:30298996) (PMCID:PMC6300803)
|
Text
160053.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. 203kB |
Abstract
No abstract available.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | McMurray, Professor John |
Authors: | Ramires, F. J.A., Martinez, F., Gómez, E. A., Demacq, C., Gimpelewicz, C. R., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., and McMurray, J. J.V. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | ESC Heart Failure |
Publisher: | Wiley |
ISSN: | 2055-5822 |
ISSN (Online): | 2055-5822 |
Published Online: | 09 October 2018 |
Copyright Holders: | Copyright © 2018 The Authors |
First Published: | First published in ESC Heart Failure 5(6): 1069-1071 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record